Annual CFF
N/A
01 December 2023
Summary:
Xenetic Biosciences annual cash flow from financing activities is not available.XBIO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
N/A
01 September 2024
Summary:
Xenetic Biosciences quarterly cash flow from financing activities is not available.XBIO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
N/A
01 September 2024
Summary:
Xenetic Biosciences TTM cash flow from financing activities is not available.XBIO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XBIO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
XBIO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Xenetic Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $11.45 M(+111.1%) | $0.00(-100.0%) | $11.45 M(-32.1%) |
| Sept 2021 | - | $11.45 M(+111.1%) | $16.88 M(+211.1%) |
| Dec 2020 | $5.43 M(-66.4%) | $5.43 M(>+9900.0%) | $5.43 M(>+9900.0%) |
| Sept 2020 | - | $0.00(-100.0%) | $1200.00(-100.0%) |
| Dec 2019 | $16.13 M(+989.7%) | $1200.00(-100.0%) | $16.13 M(+0.0%) |
| Sept 2019 | - | $13.43 M(>+9900.0%) | $16.13 M(+497.4%) |
| June 2019 | - | $500.00(-100.0%) | $2.70 M(-35.4%) |
| Mar 2019 | - | $2.70 M(>+9900.0%) | $4.18 M(+182.4%) |
| Dec 2018 | $1.48 M(>+9900.0%) | $0.00(0.0%) | $1.48 M(0.0%) |
| Sept 2018 | - | $0.00(-100.0%) | $1.48 M(0.0%) |
| June 2018 | - | $1.48 M(>+9900.0%) | $1.48 M(>+9900.0%) |
| Mar 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2017 | - | $0.00(0.0%) | $8.46 M(-10.6%) |
| June 2017 | - | $0.00(0.0%) | $9.46 M(+0.1%) |
| Mar 2017 | - | $0.00(-100.0%) | $9.46 M(-25.7%) |
| Dec 2016 | $12.72 M(+324.0%) | $8.46 M(+746.2%) | $12.72 M(+198.8%) |
| Sept 2016 | - | $1.00 M(<-9900.0%) | $4.26 M(-30.9%) |
| June 2016 | - | -$5400.00(-100.2%) | $6.16 M(-1.7%) |
| Mar 2016 | - | $3.26 M(>+9900.0%) | $6.26 M(+108.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $3.00 M(-69.4%) | $0.00(-100.0%) | $3.00 M(0.0%) |
| Sept 2015 | - | $2.90 M(+2800.0%) | $3.00 M(-1712.0%) |
| June 2015 | - | $100.00 K(>+9900.0%) | -$186.10 K(-35.0%) |
| Mar 2015 | - | $0.00(0.0%) | -$286.10 K(-102.9%) |
| Dec 2014 | $9.82 M(>+9900.0%) | $0.00(-100.0%) | $9.82 M(-1.6%) |
| Sept 2014 | - | -$286.10 K(<-9900.0%) | $9.98 M(-2.8%) |
| June 2014 | - | $0.00(-100.0%) | $10.26 M(0.0%) |
| Mar 2014 | - | $10.10 M(+6213.7%) | $10.26 M(+6313.7%) |
| Dec 2013 | $2100.00(>+9900.0%) | - | - |
| Nov 2013 | - | $160.00 K(>+9900.0%) | $160.00 K(>+9900.0%) |
| Aug 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2013 | $0.00(-100.0%) | - | - |
| May 2013 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Feb 2013 | - | $0.00(0.0%) | $35.00 K(0.0%) |
| Dec 2012 | -$303.40 K(-966.9%) | - | - |
| Nov 2012 | - | $0.00(0.0%) | $35.00 K(0.0%) |
| Aug 2012 | - | $0.00(-100.0%) | $35.00 K(0.0%) |
| Aug 2012 | $35.00 K | - | - |
| May 2012 | - | $35.00 K(>+9900.0%) | $35.00 K(>+9900.0%) |
| Feb 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2011 | - | $0.00 | $0.00 |
FAQ
- What is the all time high annual CFF for Xenetic Biosciences?
- What is the all time high quarterly CFF for Xenetic Biosciences?
- What is the all time high TTM CFF for Xenetic Biosciences?
What is the all time high annual CFF for Xenetic Biosciences?
Xenetic Biosciences all-time high annual cash flow from financing activities is $16.13 M
What is the all time high quarterly CFF for Xenetic Biosciences?
Xenetic Biosciences all-time high quarterly cash flow from financing activities is $13.43 M
What is the all time high TTM CFF for Xenetic Biosciences?
Xenetic Biosciences all-time high TTM cash flow from financing activities is $16.88 M